Pfizer Oncology Division serves as a growth driver for Pfizer’s business, contributing to improving the lives and treatment outcomes of many cancer patients through innovative medicines. In the hematologic malignancies, continued growth is expected—including a robust pipeline—starting with the launch of Elrexfio, a treatment for multiple myeloma launched in 2024.
業務内容:
Develop brand plan and drive execution in collaboration with internal and external stakeholders
Develop action plan(POA) for customer facing colleagues
Design and evaluate KPIs, manage the cycle of plan revisions based on results